Tábatha de Oliveira Silva, Guilherme Lunardon, Caroline A Lino, Amanda de Almeida Silva, Shiju Zhang, Maria Cláudia Costa Irigoyen, Yao Wei Lu, John D Mably, Maria Luiza M Barreto-Chaves, Da-Zhi Wang, Gabriela P Diniz
{"title":"Senescent Cell Depletion Alleviates Obesity-related Metabolic and Cardiac Disorders.","authors":"Tábatha de Oliveira Silva, Guilherme Lunardon, Caroline A Lino, Amanda de Almeida Silva, Shiju Zhang, Maria Cláudia Costa Irigoyen, Yao Wei Lu, John D Mably, Maria Luiza M Barreto-Chaves, Da-Zhi Wang, Gabriela P Diniz","doi":"10.1016/j.molmet.2024.102065","DOIUrl":null,"url":null,"abstract":"<p><p>Obesity is a major contributor to metabolic and cardiovascular disease. Although senescent cells have been shown to accumulate in adipose tissue, the role of senescence in obesity-induced metabolic disorders and in cardiac dysfunction is not yet clear; therefore, the therapeutic potential of managing senescence in obesity-related metabolic and cardiac disorders remains to be fully defined. We investigated the beneficial effects of a senolytic cocktail (dasatinib and quercetin) on senescence and its influence on obesity-related parameters. We found that the increase in body weight and adiposity, glucose intolerance, insulin resistance, dyslipidemia, hyperleptinemia, and hepatic disorders which were induced by an obesogenic diet were alleviated by senolytic cocktail treatment in mice. Treatment with senolytic compounds eliminated senescent cells, counteracting the activation of the senescence program and DNA damage in white adipose tissue (WAT) observed with an obesogenic diet. Moreover, the senolytic cocktail prevented the brown adipose tissue (BAT) whitening and increased the expression of the thermogenic gene profile in BAT and pWAT. In the hearts of obese mice, senolytic combination abolished myocardial maladaptation, reducing the senescence-associated secretory phenotype (SASP) and DNA damage, repressing cardiac hypertrophy, and improving diastolic dysfunction. Additionally, we showed that treatment with the senolytic cocktail corrected gene expression programs associated with fatty acid metabolism, oxidative phosphorylation, the P53 pathway, and DNA repair, which were all downregulated in obese mice. Collectively, these data suggest that a senolytic cocktail can prevent the activation of the senescence program in the heart and WAT and activate the thermogenic program in BAT. Our results suggest that targeting senescent cells may be a novel therapeutic strategy for alleviating obesity-related metabolic and cardiac disorders.</p>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":" ","pages":"102065"},"PeriodicalIF":7.0000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.molmet.2024.102065","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Obesity is a major contributor to metabolic and cardiovascular disease. Although senescent cells have been shown to accumulate in adipose tissue, the role of senescence in obesity-induced metabolic disorders and in cardiac dysfunction is not yet clear; therefore, the therapeutic potential of managing senescence in obesity-related metabolic and cardiac disorders remains to be fully defined. We investigated the beneficial effects of a senolytic cocktail (dasatinib and quercetin) on senescence and its influence on obesity-related parameters. We found that the increase in body weight and adiposity, glucose intolerance, insulin resistance, dyslipidemia, hyperleptinemia, and hepatic disorders which were induced by an obesogenic diet were alleviated by senolytic cocktail treatment in mice. Treatment with senolytic compounds eliminated senescent cells, counteracting the activation of the senescence program and DNA damage in white adipose tissue (WAT) observed with an obesogenic diet. Moreover, the senolytic cocktail prevented the brown adipose tissue (BAT) whitening and increased the expression of the thermogenic gene profile in BAT and pWAT. In the hearts of obese mice, senolytic combination abolished myocardial maladaptation, reducing the senescence-associated secretory phenotype (SASP) and DNA damage, repressing cardiac hypertrophy, and improving diastolic dysfunction. Additionally, we showed that treatment with the senolytic cocktail corrected gene expression programs associated with fatty acid metabolism, oxidative phosphorylation, the P53 pathway, and DNA repair, which were all downregulated in obese mice. Collectively, these data suggest that a senolytic cocktail can prevent the activation of the senescence program in the heart and WAT and activate the thermogenic program in BAT. Our results suggest that targeting senescent cells may be a novel therapeutic strategy for alleviating obesity-related metabolic and cardiac disorders.
肥胖是代谢和心血管疾病的主要诱因。虽然衰老细胞已被证明会在脂肪组织中积聚,但衰老在肥胖诱发的代谢紊乱和心脏功能障碍中的作用尚不明确;因此,管理衰老在肥胖相关代谢紊乱和心脏功能障碍中的治疗潜力仍有待充分确定。我们研究了抗衰老鸡尾酒(达沙替尼和槲皮素)对衰老的有益作用及其对肥胖相关参数的影响。我们发现,肥胖饮食诱发的体重和脂肪增加、葡萄糖不耐受、胰岛素抵抗、血脂异常、高瘦素血症和肝功能紊乱等症状,在小鼠体内通过解老剂鸡尾酒治疗都得到了缓解。用衰老分解化合物治疗可消除衰老细胞,抵消肥胖饮食对衰老程序的激活和白色脂肪组织(WAT)的 DNA 损伤。此外,衰老鸡尾酒还能防止棕色脂肪组织(BAT)变白,并增加 BAT 和 pWAT 中致热基因的表达。在肥胖小鼠的心脏中,衰老素组合能消除心肌适应不良,减少衰老相关分泌表型(SASP)和DNA损伤,抑制心脏肥大,改善舒张功能障碍。此外,我们还发现,肥胖小鼠体内与脂肪酸代谢、氧化磷酸化、P53 通路和 DNA 修复相关的基因表达程序均被下调,而使用衰老鸡尾酒治疗可纠正这些基因表达程序。总之,这些数据表明,衰老鸡尾酒能阻止心脏和脂肪乳中衰老程序的激活,并激活脂肪乳中的生热程序。我们的研究结果表明,针对衰老细胞可能是缓解肥胖相关代谢和心脏疾病的一种新型治疗策略。
期刊介绍:
Molecular Metabolism is a leading journal dedicated to sharing groundbreaking discoveries in the field of energy homeostasis and the underlying factors of metabolic disorders. These disorders include obesity, diabetes, cardiovascular disease, and cancer. Our journal focuses on publishing research driven by hypotheses and conducted to the highest standards, aiming to provide a mechanistic understanding of energy homeostasis-related behavior, physiology, and dysfunction.
We promote interdisciplinary science, covering a broad range of approaches from molecules to humans throughout the lifespan. Our goal is to contribute to transformative research in metabolism, which has the potential to revolutionize the field. By enabling progress in the prognosis, prevention, and ultimately the cure of metabolic disorders and their long-term complications, our journal seeks to better the future of health and well-being.